Veru does seem to be a well run company, their last financing would indicate that, and on top of Sabizabulin they also generate revenue from other products. I'm a little suprised that their valuation is not actually somewhat higher but that is only based on my opinion from a very quick look.

I agree that Zenith would seem to be more advanced in the mCRP arena but sadly I am no longer suprised that Zenith can not generate value from their assets. Management is just very poor at that very important part of their job. My hope is that at some point in the near future they will enlist a good investment banker which can get the company sold for a fair price.